The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

Emapalumab is approved for both adults and pediatric (newborn and older) patients with MAS in Still disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS.

Science X is a network of high quality websites with most complete and comprehensive daily coverage of the full sweep of science, technology, and medicine news ...

Novel, needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes Date: May 9, 2025 Source: The University of Hong Kong Summary: A research team ...

HKUMed has achieved a significant breakthrough in developing needle-free, live-attenuated influenza vaccines with broad protection against human and avian virus subtypes.

Researchers from the Shenzhen Institutes of Advanced Technology (SIAT) of the Chinese Academy of Sciences constructed a library of live attenuated influenza A vaccines that utilize diverse E3 ...

Live-attenuated respiratory syncytial virus (RSV) vaccines are highly immunogenic among HIV-exposed uninfected (HEU) pediatric patients, according to results of a study published in Open Forum ...

The vaccine, GA2, is a second-generation vaccine candidate that uses genetically attenuated — or weakened — malaria parasites that invade liver cells and develop through an early part of their ...

The lower age limit is 50 years. Live attenuated influenza vaccine Live attenuated (attenuated) influenza vaccine (LAIV) contains three types of cold-adapted, temperature-sensitive, attenuated ...